Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study

No randomized head-to-head comparison of the efficacy and safety of ticagrelor and prasugrel has been published in the 7 years since the higher efficacy of these newer P2Y inhibitors were first demonstrated relative to clopidogrel. This academic study was designed to compare the efficacy and safety...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Circulation (New York, N.Y.) Ročník 134; číslo 21; s. 1603 - 1612
Hlavní autori:	Motovska, Zuzana, Hlinomaz, Ota, Miklik, Roman, Hromadka, Milan, Varvarovsky, Ivo, Dusek, Jaroslav, Knot, Jiri, Jarkovsky, Jiri, Kala, Petr, Rokyta, Richard, Tousek, Frantisek, Kramarikova, Petra, Majtan, Bohumil, Simek, Stanislav, Branny, Marian, Mrozek, Jan, Cervinka, Pavel, Ostransky, Jiri, Widimsky, Petr
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 22.11.2016
Predmet:	Adenosine - administration & dosage Adenosine - analogs & derivatives Adenosine - therapeutic use Adult Aged Female Humans Middle Aged Myocardial Infarction - drug therapy Myocardial Infarction - pathology Myocardial Infarction - therapy Percutaneous Coronary Intervention - methods Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride - administration & dosage Prasugrel Hydrochloride - therapeutic use Ticagrelor percutaneous coronary intervention ticagrelor prasugrel hydrochloride treatment outcome safety myocardial infarction
ISSN:	1524-4539
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!